Global Achondroplasia Therapeutics Market Report By Treatment Type (Growth Hormone Therapy, Surgery, Supportive Therapy), By End-User (Hospitals, Specialty Clinics, Retail Pharmacies, Others) And By Regions - Industry Trends, Size, Share, Growth, Estimation and Forecast, 2020-2027

ID:VMR11213118
April 2021
Report Formats:
The global demand for Achondroplasia Therapeutics Market is presumed to reach the valuation of nearly USD XX MN by 2026 from USD XX MN in 2019 with a CAGR of XX% under the study period of 2020 - 2026.
 
Achondroplasia is a condition of bone growth that prevents the changing of cartilage to bone, which causes dwarfism, limited range of motion at the elbows, large head size, small fingers, and normal intelligence. Achondroplasia can be treated in two ways: first medication which causes growth hormone and secondly surgery which aimed to correct the spine, or bone problems, reduce the pressure inside the brain in cases of hydrocephaly. These treatments can only relieve causes but cannot wholly treat conditions.
 
Market Dynamics
 
The growing burden of achondroplasia is driving the growth of the market.  Achondroplasia is the most common type of dwarfism affecting about 1 in 15,000 to 1 in 40,000 people globally. The figure is growing at a steady pace annually, eventually leading to an increased demand for treatment. But there are unknown aspects of the diagnosis and treatment of achondroplasia. Inadequate reimbursement, lack of awareness, and short duration effectiveness of growth hormone therapy are projected to hamper the market growth. Genetic research on achondroplasia revealed two novel mutations, thus helping to complete the pathological molecular map of achondroplasia. The study has expanded understanding of the mechanisms and has increased the number of approaches that can be used to potentially correct it. Still, there is a need to validate these approaches in preclinical models of achondroplasia. Favorable results of validation will create opportunities for the market.
 
The report covers Porter’s Five Forces Model, Market Attractiveness Analysis and Value Chain analysis. These tools help to get a clear picture of the industry’s structure and evaluate the competition attractiveness at a global level.
 
Additionally, these tools also give inclusive assessment of each application/product segment in the global market of achondroplasia therapeutics.
 
Market Segmentation
 
The entire Achondroplasia Therapeutics market has been sub-categorized into treatment type and end-user. The report provides an analysis of these subsets with respect to the geographical segmentation. This research study will keep marketer informed and helps to identify the target demographics for a product or service.
 
By Treatment Type
  • Growth Hormone Therapy
  • Surgery
  • Supportive Therapy
 
By End-User
  • Hospitals
  • Specialty Clinics
  • Retail Pharmacies
  • Others
 
Regional Analysis
 
This section covers regional segmentation which accentuates on current and future demand for achondroplasia therapeutics market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand for individual application segment across all the prominent regions.
 
Global Achondroplasia Therapeutics Market Share by Region (Representative Graph)
 
Global Achondroplasia Therapeutics Market Share
 
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the achondroplasia therapeutics market include Ascendis Pharma A/S, BioMarin Pharmaceutical Inc., Ribomic Inc. This section includes a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
                                          
METHODOLOGY:
 
This market research report has been produced by gathering information on the basis of primary and secondary research. Secondary research has been done by using various sources which include (but not limited to) Company Websites, Paid Data Sources,  Technical Journals, Financial Reports, SEC Filings, and other different industry publications.
 
If specific information is required which is not currently within the scope of the report, it can be provided as a part of customization.

1 . PREFACE
       1.1. Report Description
           1.1.1. Objective
           1.1.2. Target Audience
           1.1.3. Unique Selling Proposition (USP) & offerings
       1.2. Research Scope
       1.3. Research Methodology
           1.3.1. Market Research Process
           1.3.2. Market Research Methodology
 
2 . EXECUTIVE SUMMARY
       2.1. Highlights of Achondroplasia Therapeutics Market
       2.2. Global Achondroplasia Therapeutics Market Snapshot
 
3 . ACHONDROPLASIA THERAPEUTICS – INDUSTRY ANALYSIS
       3.1. Introduction
       3.2. Market Drivers of Achondroplasia Therapeutics Market
       3.3. Market Restraints of Achondroplasia Therapeutics Market
       3.4. Opportunities of Achondroplasia Therapeutics Market
       3.5. Trends of Achondroplasia Therapeutics Market
       3.6. Porter’s Five Force Analysis of Achondroplasia Therapeutics Market
       3.7. Achondroplasia Therapeutics Market Attractiveness Analysis
           3.7.1 Market Attractive Analysis by Treatment Type
           3.7.2 Market Attractive Analysis by End-User
           3.7.3 Market Attractive Analysis by Region
 
4 . VALUE CHAIN ANALYSIS
       4.1. Achondroplasia Therapeutics Value Chain Analysis
       4.2. Achondroplasia Therapeutics Raw Material Analysis
           4.2.1. List of Raw Materials
           4.2.2. Achondroplasia Therapeutics Raw Material Manufactures List
           4.2.3. Price Trend of Achondroplasia Therapeutics Key Raw Materials
       4.3. List of Potential Buyers
       4.4. Marketing Channel
           4.4.1. Direct Marketing
           4.4.2. Indirect Marketing
           4.4.3. Marketing Channel Development Trend
 
5 IMPACT ANALYSIS OF COVID-19 OUTBREAK
       5.1. Impact Analysis of Covid-19 Outbreak on Achondroplasia Therapeutics Market
           5.1.1. Direct Impact on Production
           5.1.2. Supply Chain and Market Disruption
           5.1.3. Financial Impact on Firms and Financial Markets
       5.2. COVID-19 Impact Analysis by Production, Import, Export and Demand
       5.3. Achondroplasia Therapeutics Market: Pre V/S Post COVID-19
       5.4. Estimated Impact of the Coronavirus (COVID-19) Epidemic on the Achondroplasia Therapeutics Market Size in 2020, by Scenario
       5.5. COVID-19: Micro and Macro Factor Analysis on Achondroplasia Therapeutics Market
 
6 . GLOBAL ACHONDROPLASIA THERAPEUTICS MARKET ANALYSIS BY TREATMENT TYPE
       6.1 Overview by Treatment Type
       6.2 Historical Data 2015-2018
       6.3 Global Achondroplasia Therapeutics Market Analysis by Treatment Type
       6.4 Market Analysis of Growth Hormone Therapy by Regions
       6.6 Market Analysis of Surgery by Regions
       6.5 Market Analysis of Supportive Therapy by Regions
 
7 . GLOBAL ACHONDROPLASIA THERAPEUTICS MARKET ANALYSIS BY END-USER
       7.1 Overview by End-User
       7.2 Historical Data 2015-2018
       7.3 Global Achondroplasia Therapeutics Market Analysis by End-User
       7.4 Market Analysis of Hospitals by Regions
       7.5 Market Analysis of Specialty Clinics by Regions
       7.6 Market Analysis of Retail Pharmacies by Regions
       7.7 Market Analysis of Others by Regions
 
8 . GLOBAL ACHONDROPLASIA THERAPEUTICS MARKET ANALYSIS BY GEOGRAPHY
       8.1. Regional Outlook
       8.2. Introduction
       8.3. North America
           8.3.1. Overview and Historic Data
           8.3.2. North America Achondroplasia Therapeutics Market Estimate By Market Segment
           8.3.3. North America Achondroplasia Therapeutics Market Estimate By Country
           8.3.4. United State
           8.3.5. Canada
           8.3.6. Mexico
       8.4. Europe
           8.4.1. Overview and Historic Data
           8.4.2. Europe Achondroplasia Therapeutics Market Estimate by Market Segment
           8.4.3. Europe Achondroplasia Therapeutics Market Estimate by Country
           8.4.4. United Kingdom
           8.4.5. France
           8.4.6. Germany
           8.4.7. Italy
           8.4.8. Russia
           8.4.9. Rest Of Europe
       8.5. Asia Pacific
           8.5.1. Overview and Historic Data
           8.5.2. Asia Pacific Achondroplasia Therapeutics Market Estimate by Market Segment
           8.5.3. Asia Pacific Achondroplasia Therapeutics Market Estimate by Country
           8.5.4. China
           8.5.5. India
           8.5.6. Japan
           8.5.7. South Korea
           8.5.8. Australia
           8.5.9. Rest Of Asia Pacific
       8.6. Latin America
           8.6.1. Overview and Historic Data
           8.6.2. Latin America Achondroplasia Therapeutics Market Estimate by Market Segment
           8.6.3. Latin America Achondroplasia Therapeutics Market Estimate by Country
           8.6.4. Brazil
           8.6.5. Argentina
           8.6.6. Peru
           8.6.7. Chile
           8.6.8. Rest of Latin America
       8.7. Middle East & Africa
           8.7.1. Overview and Historic Data
           8.7.2. Middle East & Africa Achondroplasia Therapeutics Market Estimate by Market Segment
           8.7.3. Middle East & Africa Achondroplasia Therapeutics Market Estimate by Country
           8.7.4. Saudi Arabia
           8.7.5. UAE
           8.7.6. Israel
           8.7.7. South Africa
           8.7.8. Rest Of Middle East And Africa
 
9 . COMPETITIVE LANDSCAPE OF THE ACHONDROPLASIA THERAPEUTICS COMPANIES
       9.1. Achondroplasia Therapeutics Market Competition
       9.2. Partnership/Collaboration/Agreement
       9.3. Merger And Acquisitions
       9.4. New Product Launch
       9.5. Other Developments
 
10 . COMPANY PROFILES OF ACHONDROPLASIA THERAPEUTICS INDUSTRY
       10.1. Company Share Analysis
       10.2. Market Concentration Rate
       10.3. Ascendis Pharma A/S
           10.3.1. Company Overview
           10.3.2. Financials
           10.3.3. Products
           10.3.4. Recent Developments
       10.4. BioMarin Pharmaceutical Inc
           10.4.1. Company Overview
           10.4.2. Financials
           10.4.3. Products
           10.4.4. Recent Developments
       10.5. Ribomic Inc.
           10.5.1. Company Overview
           10.5.2. Financials
           10.5.3. Products
           10.5.4. Recent Developments
 
 *Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies
 
LIST OF TABLES

  • Global Achondroplasia Therapeutics Market Snapshot
  • Drivers of The Global Achondroplasia Therapeutics Market Impact Analysis
  • Restraints of The Global Achondroplasia Therapeutics Market Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • List of Potential Buyers
  • COVID-19 Impact Analysis by Production, Import, Export and Demand
  • Achondroplasia Therapeutics Market: Pre V/S Post COVID-19
  • Estimated Impact Of The Coronavirus (Covid-19) Epidemic On The Achondroplasia Therapeutics Market Size In 2020, By Scenario
  • COVID-19: Micro and Macro Factor Analysis on Achondroplasia Therapeutics Market
  • Global Achondroplasia Therapeutics Market Analysis by Treatment Type ( USD MN)
  • Historic Data 2015-2018
  • Global Achondroplasia Therapeutics Market Analysis in Growth Hormone Therapy by Geography ( USD MN)
  • Global Achondroplasia Therapeutics Market Analysis in Surgery by Geography ( USD MN)
  • Global Achondroplasia Therapeutics Market Analysis in Supportive Therapy by Geography ( USD MN)
  • Global Achondroplasia Therapeutics Market Analysis by End-User ( USD MN)
  • Historic Data 2015-2018
  • Global Achondroplasia Therapeutics Market Analysis in Hospitals by Geography ( USD MN)
  • Global Achondroplasia Therapeutics Market Analysis in Specialty Clinics by Geography ( USD MN)
  • Global Achondroplasia Therapeutics Market Analysis in Retail Pharmacies by Geography ( USD MN)
  • Global Achondroplasia Therapeutics Market Analysis in Others by Geography ( USD MN)
  • Global Achondroplasia Therapeutics Market by Geography ( USD MN)
  • Historic Data 2015-2018
  • North America Achondroplasia Therapeutics Market Analysis by Treatment Type ( USD MN)
  • North America Achondroplasia Therapeutics Market Estimate by End-User ( USD MN)
  • North America Achondroplasia Therapeutics Market Estimate by Country ( USD MN)
  • United State Achondroplasia Therapeutics Market Analysis by Treatment Type ( USD MN)
  • United State Achondroplasia Therapeutics Market Estimate by End-User ( USD MN)
  • Canada Achondroplasia Therapeutics Market Analysis by Treatment Type ( USD MN)
  • Canada Achondroplasia Therapeutics Market Estimate by End-User ( USD MN)
  • Mexico Achondroplasia Therapeutics Market Analysis by Treatment Type ( USD MN)
  • Mexico Achondroplasia Therapeutics Market Estimate by End-User ( USD MN)
  • Europe Achondroplasia Therapeutics Market Analysis by Treatment Type ( USD MN)
  • Europe Achondroplasia Therapeutics Market Estimate by End-User ( USD MN)
  • Europe Achondroplasia Therapeutics Market Estimate by Country ( USD MN)
  • United Kingdom Achondroplasia Therapeutics Market Analysis by Treatment Type ( USD MN)
  • United Kingdom Achondroplasia Therapeutics Market Estimate by End-User ( USD MN)
  • France Achondroplasia Therapeutics Market Analysis by Treatment Type ( USD MN)
  • France Achondroplasia Therapeutics Market Estimate by End-User ( USD MN)
  • Germany Achondroplasia Therapeutics Market Analysis by Treatment Type ( USD MN)
  • Germany Achondroplasia Therapeutics Market Estimate by End-User ( USD MN)
  • Italy Achondroplasia Therapeutics Market Analysis by Treatment Type ( USD MN)
  • Italy Achondroplasia Therapeutics Market Estimate by End-User ( USD MN)
  • Russia Achondroplasia Therapeutics Market Analysis by Treatment Type ( USD MN)
  • Russia Achondroplasia Therapeutics Market Estimate by End-User ( USD MN)
  • Spain Achondroplasia Therapeutics Market Analysis by Treatment Type ( USD MN)
  • Spain Achondroplasia Therapeutics Market Estimate by End-User ( USD MN)
  • Rest of Europe Achondroplasia Therapeutics Market Analysis by Treatment Type ( USD MN)
  • Rest of Europe Achondroplasia Therapeutics Market Estimate by End-User ( USD MN)
  • Asia Pacific Achondroplasia Therapeutics Market Analysis by Treatment Type ( USD MN)
  • Asia Pacific Achondroplasia Therapeutics Market Estimate by End-User ( USD MN)
  • Asia Pacific Achondroplasia Therapeutics Market Estimate by Country ( USD MN)
  • China Achondroplasia Therapeutics Market Analysis by Treatment Type ( USD MN)
  • China Achondroplasia Therapeutics Market Estimate by End-User ( USD MN)
  • Japan Achondroplasia Therapeutics Market Analysis by Treatment Type ( USD MN)
  • Japan Achondroplasia Therapeutics Market Estimate by End-User ( USD MN)
  • India Achondroplasia Therapeutics Market Analysis by Treatment Type ( USD MN)
  • India Achondroplasia Therapeutics Market Estimate by End-User ( USD MN)
  • South Korea Achondroplasia Therapeutics Market Analysis by Treatment Type ( USD MN)
  • South Korea Achondroplasia Therapeutics Market Estimate by End-User ( USD MN)
  • Australia Achondroplasia Therapeutics Market Analysis by Treatment Type ( USD MN)
  • Australia Achondroplasia Therapeutics Market Estimate by End-User ( USD MN)
  • Rest of Asia Pacific Achondroplasia Therapeutics Market Analysis by Treatment Type ( USD MN)
  • Rest of Asia Pacific Achondroplasia Therapeutics Market Estimate by End-User ( USD MN)
  • Latin America Achondroplasia Therapeutics Market Analysis by Treatment Type ( USD MN)
  • Latin America Achondroplasia Therapeutics Market Estimate by End-User ( USD MN)
  • Latin America Achondroplasia Therapeutics Market Estimate by Country ( USD MN)
  • Brazil Achondroplasia Therapeutics Market Analysis by Treatment Type ( USD MN)
  • Brazil Achondroplasia Therapeutics Market Estimate by End-User ( USD MN)
  • Argentina Achondroplasia Therapeutics Market Analysis by Treatment Type ( USD MN)
  • Argentina Achondroplasia Therapeutics Market Estimate by End-User ( USD MN)
  • Peru Achondroplasia Therapeutics Market Analysis by Treatment Type ( USD MN)
  • Peru Achondroplasia Therapeutics Market Estimate by End-User ( USD MN)
  • Chile Achondroplasia Therapeutics Market Analysis by Treatment Type ( USD MN)
  • Chile Achondroplasia Therapeutics Market Estimate by End-User ( USD MN)
  • Rest of Latin America Achondroplasia Therapeutics Market Analysis by Treatment Type ( USD MN)
  • Rest of Latin America Achondroplasia Therapeutics Market Estimate by End-User ( USD MN)
  • Middle East & Africa Achondroplasia Therapeutics Market Analysis by Treatment Type ( USD MN)
  • Middle East & Africa Achondroplasia Therapeutics Market Estimate by End-User ( USD MN)
  • Middle East & Africa Achondroplasia Therapeutics Market Estimate by Country ( USD MN)
  • Saudi Arabia Achondroplasia Therapeutics Market Analysis by Treatment Type ( USD MN)
  • Saudi Arabia Achondroplasia Therapeutics Market Estimate by End-User ( USD MN)
  • UAE Achondroplasia Therapeutics Market Analysis by Treatment Type ( USD MN)
  • UAE Achondroplasia Therapeutics Market Estimate by End-User ( USD MN)
  • Israel Achondroplasia Therapeutics Market Analysis by Treatment Type ( USD MN)
  • Israel Achondroplasia Therapeutics Market Estimate by End-User ( USD MN)
  • South Africa Achondroplasia Therapeutics Market Analysis by Treatment Type ( USD MN)
  • South Africa Achondroplasia Therapeutics Market Estimate by End-User ( USD MN)
  • Rest of Middle East and Africa Achondroplasia Therapeutics Market Analysis by Treatment Type ( USD MN)
  • Rest of Middle East and Africa Achondroplasia Therapeutics Market Estimate by End-User ( USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisiton
 
LIST OF FIGURES
 
  • Research Scope of Achondroplasia Therapeutics Report
  • Market Research Process
  • Market Research Methodology
  • Global Achondroplasia Therapeutics Market Size, by Region (2019)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis by Treatment Type
  • Market Attractiveness Analysis by End-User
  • Market Attractiveness Analysis by Region
  • Value Chain Analysis
  • Global Achondroplasia Therapeutics Market Analysis by Treatment Type
  • Global Achondroplasia Therapeutics Market Analysis in Growth Hormone Therapy by Region
  • Global Achondroplasia Therapeutics Market Analysis in Surgery by Region
  • Global Achondroplasia Therapeutics Market Analysis in Supportive Therapy by Region
  • Global Achondroplasia Therapeutics Market Analysis by End-User
  • Global Achondroplasia Therapeutics Market Analysis in Hospitals by Region
  • Global Achondroplasia Therapeutics Market Analysis in Specialty Clinics by Region
  • Global Achondroplasia Therapeutics Market Analysis in Retail Pharmacies by Region
  • Global Achondroplasia Therapeutics Market Analysis in Others by Region
  • Global Achondroplasia Therapeutics Market by Revenue
  • North America Achondroplasia Therapeutics Market by Revenue
  • Europe Achondroplasia Therapeutics Market by Revenue
  • Asia Pacific Achondroplasia Therapeutics Market by Revenue
  • Latin America Achondroplasia Therapeutics Market by Revenue
  • Middle East & Africa Achondroplasia Therapeutics Market by Revenue
  • Recent Development in Achondroplasia Therapeutics Industry
  • Company Market Share Analysis, 2019
 
* Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.

Buy Chapters or Sections

Avail customized purchase options to meet your exact research needs:

  • Buy sections of this report
  • Buy country level reports
  • Request for historical data
  • Request discounts available for Start-Ups & Universities

Objectives of Study

  • Define and measure the global market
  • Volume or revenue forecast of the global market and its various sub-segments with respect to main geographies
  • Analyze and identify major market trends along with the factors driving or inhibiting the market growth
  • Study the company profiles of the major market players with their market share
  • Analyze competitive developments

Why Choose Us

Client First Policy
Excellent Quality
Robust After Sales Support
24/7 Email Support

Clients

Testimonials